After finishing at $4.29 in the prior trading day, Ardelyx Inc (NASDAQ: ARDX) closed at $4.28, down -0.23%. In other words, the price has decreased by -$0.23 from its previous closing price. On the day, 3.17 million shares were traded. ARDX stock price reached its highest trading level at $4.3984 during the session, while it also had its lowest trading level at $4.245.
Ratios:
Our goal is to gain a better understanding of ARDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 4.12. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 1.06.
On May 02, 2025, Raymond James Downgraded its rating to Outperform which previously was Strong Buy but kept the price unchanged to $11.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 16 ’25 when MOTT DAVID M bought 200,000 shares for $3.63 per share. The transaction valued at 725,880 led to the insider holds 2,896,871 shares of the business.
MOTT DAVID M bought 200,000 shares of ARDX for $737,260 on Jun 09 ’25. The Director now owns 2,696,871 shares after completing the transaction at $3.69 per share. On May 20 ’25, another insider, Williams Laura A, who serves as the Chief Medical Officer of the company, sold 6,421 shares for $4.08 each. As a result, the insider received 26,207 and left with 402,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1026403968 and an Enterprise Value of 991690304. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.83 while its Price-to-Book (P/B) ratio in mrq is 7.03. Its current Enterprise Value per Revenue stands at 2.742 whereas that against EBITDA is -26.522.
Stock Price History:
The Beta on a monthly basis for ARDX is 0.68, which has changed by -0.22463769 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, ARDX has reached a high of $7.18, while it has fallen to a 52-week low of $3.21. The 50-Day Moving Average of the stock is 6.62%, while the 200-Day Moving Average is calculated to be -12.82%.
Shares Statistics:
The stock has traded on average 5.16M shares per day over the past 3-months and 3075930 shares per day over the last 10 days, according to various share statistics. A total of 239.20M shares are outstanding, with a floating share count of 230.36M. Insiders hold about 3.72% of the company’s shares, while institutions hold 71.35% stake in the company. Shares short for ARDX as of 1752537600 were 27588838 with a Short Ratio of 5.34, compared to 1749772800 on 27283637. Therefore, it implies a Short% of Shares Outstanding of 27588838 and a Short% of Float of 13.059999999999999.
Earnings Estimates
The firm’s stock currently is rated by 6.0 analysts. The consensus estimate for the next quarter is -$0.09, with high estimates of -$0.04 and low estimates of -$0.12.
Analysts are recommending an EPS of between -$0.4 and -$0.49 for the fiscal current year, implying an average EPS of -$0.44. EPS for the following year is $0.05, with 6.0 analysts recommending between $0.29 and -$0.19.
Revenue Estimates
12 analysts predict $81.85M in revenue for the current quarter. It ranges from a high estimate of $90.5M to a low estimate of $72.5M. As of the current estimate, Ardelyx Inc’s year-ago sales were $73.22MFor the next quarter, 12 analysts are estimating revenue of $94.75M. There is a high estimate of $99.7M for the next quarter, whereas the lowest estimate is $84.4M.
A total of 12 analysts have provided revenue estimates for ARDX’s current fiscal year. The highest revenue estimate was $378.6M, while the lowest revenue estimate was $341.7M, resulting in an average revenue estimate of $360.14M. In the same quarter a year ago, actual revenue was $333.62MBased on 12 analysts’ estimates, the company’s revenue will be $476.7M in the next fiscal year. The high estimate is $559.8M and the low estimate is $393.7M.
